Washington Trust Bank’s Avanos Medical AVNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-58
Closed -$2K 223
2019
Q1
$2K Sell
58
-57
-50% -$2.55K ﹤0.01% 550
2018
Q4
$5K Hold
115
﹤0.01% 534
2018
Q3
$8K Hold
115
﹤0.01% 553
2018
Q2
$7K Hold
115
﹤0.01% 552
2018
Q1
$5K Hold
115
﹤0.01% 670
2017
Q4
$5K Hold
115
﹤0.01% 648
2017
Q3
$5K Hold
115
﹤0.01% 626
2017
Q2
$5K Hold
115
﹤0.01% 567
2017
Q1
$4K Hold
115
﹤0.01% 623
2016
Q4
$4K Hold
115
﹤0.01% 628
2016
Q3
$4K Sell
115
-250
-68% -$8.76K ﹤0.01% 621
2016
Q2
$12K Sell
365
-25
-6% -$766 ﹤0.01% 544
2016
Q1
$11K Sell
390
-667
-63% -$17.8K ﹤0.01% 573
2015
Q4
$35K Buy
1,057
+115
+12% +$3.58K 0.01% 446
2015
Q3
$27K Sell
942
-16
-2% -$558 0.01% 487
2015
Q2
$39K Sell
958
-1,240
-56% -$55.7K 0.01% 469
2015
Q1
$108K Buy
+2,198
New +$102K 0.03% 314

Other funds holding AVNS

Washington Trust Bank's AVNS Position: Q2 2019 in Review

Washington Trust Bank sold out of Avanos Medical (AVNS) in Q2 2019, closing a stake of 58 shares — an estimated $2K sold.

Washington Trust Bank first reported a position in AVNS in Q1 2015 and held it in 17 quarters. The position peaked at $108K in Q1 2015. 317 funds tracked by Wall St. Rank hold AVNS as of Q2 2019.

  • Washington Trust Bank reported no remaining Avanos Medical position as of Q2 2019 after selling out during the quarter.
  • Washington Trust Bank sold 58 Avanos Medical shares in Q2 2019, an estimated $2K.
  • Washington Trust Bank first reported a position in Avanos Medical in Q1 2015 and held it in 17 quarters.
  • Washington Trust Bank's Avanos Medical position peaked at $108K in Q1 2015.
  • 317 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2019.

Based on Washington Trust Bank's 13F filing for Q2 2019, filed 26 Jul 2019.